Cipher Pharmaceuticals, Inc. (CPH.TO)
14.14
+0.04
(+0.28%)
CAD |
TSX |
Aug 25, 10:03
Cipher Pharmaceuticals Net Income (Quarterly) : 5.556M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.556M |
| March 31, 2026 | 8.454M |
| December 31, 2025 | 18.56M |
| September 30, 2025 | 7.576M |
| June 30, 2025 | 8.160M |
| March 31, 2025 | 3.765M |
| December 31, 2024 | 4.676M |
| September 30, 2024 | 0.386M |
| June 30, 2024 | 4.098M |
| March 31, 2024 | 6.639M |
| December 31, 2023 | 10.43M |
| September 30, 2023 | 9.430M |
| June 30, 2023 | 4.124M |
| March 31, 2023 | 3.552M |
| December 31, 2022 | 26.72M |
| September 30, 2022 | 3.466M |
| June 30, 2022 | 2.748M |
| March 31, 2022 | 2.722M |
| December 31, 2021 | 3.544M |
| September 30, 2021 | 1.003M |
| June 30, 2021 | 3.458M |
| March 31, 2021 | 1.696M |
| December 31, 2020 | -0.1303M |
| September 30, 2020 | 2.136M |
| June 30, 2020 | 0.5694M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.332M |
| December 31, 2019 | 3.493M |
| September 30, 2019 | -2.882M |
| June 30, 2019 | 1.818M |
| March 31, 2019 | 1.085M |
| December 31, 2018 | -0.6616M |
| September 30, 2018 | 0.9646M |
| June 30, 2018 | 2.473M |
| March 31, 2018 | -1.203M |
| December 31, 2017 | 4.987M |
| September 30, 2017 | 4.880M |
| June 30, 2017 | 5.92M |
| March 31, 2017 | -2.107M |
| December 31, 2016 | -0.0253M |
| September 30, 2016 | 2.898M |
| June 30, 2016 | 0.3017M |
| March 31, 2016 | 2.449M |
| December 31, 2015 | 2.724M |
| September 30, 2015 | -2.899M |
| June 30, 2015 | -0.6861M |
| March 31, 2015 | 3.856M |
| December 31, 2014 | 3.624M |
| September 30, 2014 | 8.656M |
| June 30, 2014 | 4.505M |
| March 31, 2014 | 3.866M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -1.412M |
| Bausch Health Cos., Inc. | 359.94M |
| BioSyent, Inc. | 2.849M |
| Revive Therapeutics Ltd. | -0.5065M |
| Knight Therapeutics, Inc. | -3.361M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 16.71M |
| Total Expenses (Quarterly) | 11.15M |
| EPS Diluted (Quarterly) | 0.2138 |
| Enterprise Value | 345.95M |
| Gross Profit Margin (Quarterly) | 65.58% |
| Profit Margin (Quarterly) | 33.26% |
| Earnings Yield | 10.97% |
| Operating Earnings Yield | 7.28% |
| Normalized Earnings Yield | 10.97 |